In a significant breakthrough for cystic fibrosis therapeutics focusing on child-care, Vertex Pharmaceuticals’s TRIKAFTA, has received US FDA approval. Post the US Food and Drug Administration…
In a significant breakthrough for cystic fibrosis therapeutics focusing on child-care, Vertex Pharmaceuticals’s TRIKAFTA, has received US FDA approval. Post the US Food and Drug Administration…